Korea / Special Situations, Clepsydra Capital

Sanghyun Park

Korea / Special Situations

Korea / Special Sits, Pairs, Index Rebalancing

Clepsydra Capital

Investigate special situations, pairs, and index rebalancing trades in Korea.

Event-Driven

<ul>
<li>Samsung Biologics is spinning off Samsung Bio Holdings, transferring full Samsung Bioepis shares; shareholders keep stakes in both, with an expected 70:30 split favoring Biologics.</li>
<li>Post-Split, major shareholders keep stakes; they’ll transfer Biologics shares to Bio Holdings, which becomes parent owning 74.34% Biologics and 100% Bioepis, meeting holding company rules.</li>
<li>Samsung C&amp;T’s restructuring carves out Biologics into a holdco, lowering valuation to avoid forced holding company conversion and enabling future Samsung Electronics share acquisition.</li>
</ul>


Samsung Biologics is spinning off Samsung Bio Holdings, transferring full Samsung Bioepis shares; shareholders keep stakes in both, with an expected 70:30 split favoring Biologics.
Post-Split, major shareholders keep stakes; they’ll transfer Biologics shares to Bio Holdings, which becomes parent owning 74.34% Biologics and 100% Bioepis, meeting holding company rules.
Samsung C&amp;T’s restructuring carves out Biologics into a holdco, lowering valuation to avoid forced holding company conversion and enabling future Samsung Electronics share acquisition.


Intel Summary on Samsung Biologics Split and Samsung C&T’s Acquisition of Samsung Electronics Shares

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Douglas Research Advisory

Equity Bottom-Up

<ul>
<li>On 20 May, Samsung C&amp;T (028260 KS) made an important announcement that it started research and development on a space project that includes a rocket launch facility construction.</li>
<li>This is a signal that the Samsung Group may be interested in expanding in the global defense/aerospace industry once again. </li>
<li>The recent news flow on Samsung's expansion into aerospace business including Samsung C&amp;T's development of rocket launch facility is likely to positively impact Samsung C&amp;T's share price. </li>
</ul>


On 20 May, Samsung C&amp;T (028260 KS) made an important announcement that it started research and development on a space project that includes a rocket launch facility construction.
This is a signal that the Samsung Group may be interested in expanding in the global defense/aerospace industry once again. 
The recent news flow on Samsung's expansion into aerospace business including Samsung C&amp;T's development of rocket launch facility is likely to positively impact Samsung C&amp;T's share price. 


Samsung C&T: Entrance into the Global Aerospace Industry [Watch What They Do, Not What They Say]

<ul>
<li>Jay Lee’s clean Supreme Court win may cool Samsung’s governance trade near term. With legal risks gone, there’s less urgency to push structural changes or shuffle shares now.</li>
<li>Samsung C&amp;T, a hotspot for governance spec flows, may see bids fade as urgency for structural shifts drops; longs on revamp bets might consider fading or shorting amid lingering risks.</li>
<li>Samsung Life gets relief as forced Elec share sales drop, supporting its stock. Samsung Elec stays neutral. Trade idea: Samsung Life long, Samsung C&amp;T short on cooled governance hopes.</li>
</ul>


Jay Lee’s clean Supreme Court win may cool Samsung’s governance trade near term. With legal risks gone, there’s less urgency to push structural changes or shuffle shares now.
Samsung C&amp;T, a hotspot for governance spec flows, may see bids fade as urgency for structural shifts drops; longs on revamp bets might consider fading or shorting amid lingering risks.
Samsung Life gets relief as forced Elec share sales drop, supporting its stock. Samsung Elec stays neutral. Trade idea: Samsung Life long, Samsung C&amp;T short on cooled governance hopes.


Samsung Jay Lee Cleared by Supreme Court — Market Reaction Could Flip From Consensus

<ul>
<li>Now that Lee Jae-Yong's legal problems appear to have finally have been resolved, it could positively impact Samsung C&amp;T, Samsung Electronics, and Samsung Biologics.</li>
<li>Given the fact that Samsung Electronics and Samsung Biologics are the two most important drivers of Samsung C&amp;T, this could positively benefit the valuation of Samsung C&amp;T. </li>
<li>Our NAV analysis of Samsung C&amp;T suggests NAV of 38.7 trillion won or NAV per share of 217,747 won which is 84% higher from current levels.</li>
</ul>


Now that Lee Jae-Yong's legal problems appear to have finally have been resolved, it could positively impact Samsung C&amp;T, Samsung Electronics, and Samsung Biologics.
Given the fact that Samsung Electronics and Samsung Biologics are the two most important drivers of Samsung C&amp;T, this could positively benefit the valuation of Samsung C&amp;T. 
Our NAV analysis of Samsung C&amp;T suggests NAV of 38.7 trillion won or NAV per share of 217,747 won which is 84% higher from current levels.


Acquittal of Lee Jae-Yong and Impact on Samsung C&T

<ul>
<li>In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in 1Q 2025.</li>
<li>The recent martial law cancellation and numerous impeachments of acting Presidents have raised political uncertainty in Korea resulting in widening of some gaps among numerous holdcos and opcos in Korea.</li>
<li>Of the 38 pair trades, 25 of them involved holdcos outperforming opcos in the past six months and the other 13 opcos outperforming holdcos in the same period.</li>
</ul>


In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in 1Q 2025.
The recent martial law cancellation and numerous impeachments of acting Presidents have raised political uncertainty in Korea resulting in widening of some gaps among numerous holdcos and opcos in Korea.
Of the 38 pair trades, 25 of them involved holdcos outperforming opcos in the past six months and the other 13 opcos outperforming holdcos in the same period.


Korean Holdcos Vs Opcos Gap Trading Opportunities in 1Q 2025

South Korea

Samsung C&T Corporation conducts diversified business support services and resort operation activities. The Company offers a range of services in areas including clothing retail, construction, energy, real estate, food service, and resort accommodations. Samsung C&T also operates a resort with amusement rides, a zoo, water park, golf clubs, and restaurants.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Samsung C&T (028260 KS)

Intel Summary on Samsung Biologics Split and Samsung C&T’s Acquisition of Samsung Electronics Shares

This post breaks down the latest intel on Samsung Biologics’ split and Samsung C&T’s move to snap up Samsung Electronics shares.

Sanghyun Park

Samsung C&T: Entrance into the Global Aerospace Industry [Watch What They Do, Not What They Say]

The recent news flow on Samsung's expansion into aerospace business including Samsung C&T's development of rocket launch facility is likely to...

Douglas Kim

Samsung Jay Lee Cleared by Supreme Court — Market Reaction Could Flip From Consensus

Samsung Jay Lee’s final legal overhang just got wiped clean with the Supreme Court’s not-guilty stamp — but the market move might actually play out...

Sanghyun Park

Acquittal of Lee Jae-Yong and Impact on Samsung C&T

Now that Lee Jae-Yong's legal problems appear to have finally have been resolved, it could positively impact Samsung C&T, Samsung Electronics, and...

Douglas Kim

Korean Holdcos Vs Opcos Gap Trading Opportunities in 1Q 2025

In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...

Douglas Kim

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)